151 related articles for article (PubMed ID: 32557180)
1. The Effect of Positively Framing Side-Effect Risk in Two Different Formats on Side-Effect Expectations, Informed Consent and Credibility: A Randomised Trial of 16- to 75-Year-Olds in England.
Webster RK; Rubin GJ
Drug Saf; 2020 Oct; 43(10):1011-1022. PubMed ID: 32557180
[TBL] [Abstract][Full Text] [Related]
2. Positively Framed Risk Information in Patient Information Leaflets Reduces Side Effect Reporting: A Double-Blind Randomized Controlled Trial.
Webster RK; Weinman J; Rubin GJ
Ann Behav Med; 2018 Oct; 52(11):920-929. PubMed ID: 30346496
[TBL] [Abstract][Full Text] [Related]
3. How does the side-effect information in patient information leaflets influence peoples' side-effect expectations? A cross-sectional national survey of 18- to 65-year-olds in England.
Webster RK; Weinman J; Rubin GJ
Health Expect; 2017 Dec; 20(6):1411-1420. PubMed ID: 28618140
[TBL] [Abstract][Full Text] [Related]
4. The OMACS-PIL study: a randomised controlled trial within the OMACS observational study.
Culliford L; Brierley R; Clout M; Evans R; Maishman R; Phillips D; Tabusa H; Reeves B; Rogers CA
Trials; 2019 Dec; 20(1):772. PubMed ID: 31881927
[TBL] [Abstract][Full Text] [Related]
5. Predicting Expectations of Side-Effects for Those Which Are Warned Versus Not Warned About in Patient Information Leaflets.
Webster RK; Rubin GJ
Ann Behav Med; 2021 Nov; 55(12):1253-1261. PubMed ID: 33821932
[TBL] [Abstract][Full Text] [Related]
6. Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols.
Murphy E; Gillies K; Shiely F
Trials; 2024 Jun; 25(1):372. PubMed ID: 38858790
[TBL] [Abstract][Full Text] [Related]
7. Utility of patient information leaflet and perceived impact of its use on medication adherence.
Al Jeraisy M; Alshammari H; Albassam M; Al Aamer K; Abolfotouh MA
BMC Public Health; 2023 Mar; 23(1):488. PubMed ID: 36918823
[TBL] [Abstract][Full Text] [Related]
8. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
Trials; 2014 Feb; 15():62. PubMed ID: 24548781
[TBL] [Abstract][Full Text] [Related]
9. Applying behavioural science to increase uptake of the NHS Health Check: a randomised controlled trial of gain- and loss-framed messaging in the national patient information leaflet.
Gold N; Durlik C; Sanders JG; Thompson K; Chadborn T
BMC Public Health; 2019 Nov; 19(1):1519. PubMed ID: 31727030
[TBL] [Abstract][Full Text] [Related]
10. When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
Cuddihy L; Howick J; Murphy E; Shiely F
Trials; 2024 May; 25(1):292. PubMed ID: 38693579
[TBL] [Abstract][Full Text] [Related]
11. People's Understanding of Verbal Risk Descriptors in Patient Information Leaflets: A Cross-Sectional National Survey of 18- to 65-Year-Olds in England.
Webster RK; Weinman J; Rubin GJ
Drug Saf; 2017 Aug; 40(8):743-754. PubMed ID: 28497250
[TBL] [Abstract][Full Text] [Related]
12. Patient information leaflets for placebo-controlled surgical trials: a review of current practice and recommendations for developers.
Cousins S; Huttman M; Blencowe N; Tsang C; Elliott D; Blazeby J; Beard DJ; Campbell MK; Gillies K
Trials; 2024 May; 25(1):339. PubMed ID: 38778336
[TBL] [Abstract][Full Text] [Related]
13. Nocebo effects of a simplified package leaflet compared to unstandardised oral information and a standard package leaflet: a pilot randomised controlled trial.
Prediger B; Meyer E; Büchter R; Mathes T
Trials; 2019 Jul; 20(1):458. PubMed ID: 31349865
[TBL] [Abstract][Full Text] [Related]
14. Changes in Side Effect Risk Communication in Patient Information Leaflets over the Past Decade: Results of a Survey.
Harris K; Dickinson R; Raynor DK; MacDonald J; Knapp P
Drug Saf; 2015 Aug; 38(8):721-7. PubMed ID: 26100144
[TBL] [Abstract][Full Text] [Related]
15. Framing and personalizing informed consent to prevent negative expectations: An experimental pilot study.
Heisig SR; Shedden-Mora MC; Hidalgo P; Nestoriuc Y
Health Psychol; 2015 Oct; 34(10):1033-1037. PubMed ID: 25689300
[TBL] [Abstract][Full Text] [Related]
16. The development of patient information leaflets incorporating patient diversity considerations: Varicocele embolisation and fluoroscopy guided joint injection examinations.
Vassallo T; Mizzi A; Depasquale R; Maher M; Rainford L
Radiography (Lond); 2018 Oct; 24 Suppl 1():S20-S27. PubMed ID: 30166004
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the Readability of Dermatological Postoperative Patient Information Leaflets Across England.
Hunt WT; McGrath EJ
Dermatol Surg; 2016 Jun; 42(6):757-63. PubMed ID: 27176870
[TBL] [Abstract][Full Text] [Related]
18. Relative importance of informational items in participant information leaflets for trials: a Q-methodology approach.
Innes K; Cotton S; Campbell MK; Elliott J; Gillies K
BMJ Open; 2018 Sep; 8(9):e023303. PubMed ID: 30185580
[TBL] [Abstract][Full Text] [Related]
19. Does different information disclosure on placebo control affect blinding and trial outcomes? A case study of participant information leaflets of randomized placebo-controlled trials of acupuncture.
Cheon S; Park HJ; Chae Y; Lee H
BMC Med Res Methodol; 2018 Jan; 18(1):13. PubMed ID: 29347917
[TBL] [Abstract][Full Text] [Related]
20. Impact of patient information leaflets on doctor-patient communication in the context of acute conditions: a prospective, controlled, before-after study in two French emergency departments.
Sustersic M; Tissot M; Tyrant J; Gauchet A; Foote A; Vermorel C; Bosson JL
BMJ Open; 2019 Feb; 9(2):e024184. PubMed ID: 30787085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
